REFERENCES
1. Ahmad U, Yao X, Detterbeck F, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg 2015;149:95-100, 101.e1.
2. Chung DA. Thymic carcinoma--analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg 2000;48:114-9.
3. Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas CR Jr. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 2004;59:654-64.
4. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-84; discussion 884.
5. Quagliano PV. Thymic carcinoma: case reports and review. J Thorac Imaging 1996;11:66-74.
6. Nasseri F, Eftekhari F. Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls. Radiographics 2010;30:413-28.
7. Roden AC, Erickson-Johnson MR, Yi ES, García JJ. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus. Hum Pathol 2013;44:2799-805.
8. Zettl A, Ströbel P, Wagner K, et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 2000;157:257-66.
9. Radovich M, Pickering CR, Felau I, et al. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell 2018;33:244-58.e10.
10. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 1991;67:1025-32.
11. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 1996;20:1469-80.
13. Weissferdt A, Moran CA. Immunohistochemistry in the diagnosis of thymic epithelial neoplasms. Appl Immunohistochem Mol Morphol 2014;22:479-87.
14. Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 2005;128:140-4.
15. Pan CC, Chen PC, Chiang H. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol 2004;202:375-81.
16. Marx A, Chan JK, Coindre JM, et al. The 2015 World Health Organization Classification of tumors of the thymus: continuity and changes. J Thorac Oncol 2015;10:1383-95.
17. Truong LD, Mody DR, Cagle PT, Jackson-York GL, Schwartz MR, Wheeler TM. Thymic carcinoma. A clinicopathologic study of 13 cases. Am J Surg Pathol 1990;14:151-66.
18. Moran CA, Suster S. Mucoepidermoid carcinomas of the thymus. A clinicopathologic study of six cases. Am J Surg Pathol 1995;19:826-34.
19. Snover DC, Levine GD, Rosai J. Thymic carcinoma. Five distinctive histological variants. Am J Surg Pathol 1982;6:451-70.
20. . WHO Classification of Tumours Editorial Board. Thoracic tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2021
21. Weissferdt A, Moran CA. Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 2012;138:103-14.
22. Weksler B, Dhupar R, Parikh V, Nason KS, Pennathur A, Ferson PF. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 2013;95:299-303.
23. Zhao Y, Zhao H, Hu D, Fan L, Shi J, Fang W. Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. Ann Thorac Surg 2013;96:1019-24.
24. Girard N, Shen R, Guo T, et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 2009;15:6790-9.
25. Suster D, Pihan G, Mackinnon AC, Suster S. Poorly differentiated nonkeratinizing squamous cell carcinoma of the thymus: clinicopathologic and molecular genetic study of 25 cases. Am J Surg Pathol 2018;42:1224-36.
26. Thomas de Montpreville V, Mansuet-Lupo A, Le Naoures C, et al. Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC study. Virchows Arch 2021;479:741-6.
27. Brown JG, Familiari U, Papotti M, Rosai J. Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma. Am J Surg Pathol 2009;33:1113-24.
28. Chalabreysse L, Etienne-Mastroianni B, Adeleine P, Cordier JF, Greenland T, Thivolet-Bejui F. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology 2004;44:367-74.
29. Hishida T, Nomura S, Yano M, et al. Japanese Association for Research on the Thymus (JART). Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg 2016;49:835-41.
30. Leyvraz S, Henle W, Chahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985;312:1296-9.
31. Xu M, Yao Y, Chen H, et al. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nat Genet 2019;51:1131-6.
32. Zhang G, Yu Z, Shen G, Chai Y, Liang C. Association between Epstein-Barr virus and Thymic epithelial tumors: a systematic review. Infect Agent Cancer 2019;14:32.
33. Suster D, Pihan G, Mackinnon AC, Suster S. Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus. Mod Pathol 2018;31:1801-6.
34. Suster S, Moran CA. Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm. Am J Surg Pathol 1999;23:691-700.
35. Moritani S, Ichihara S, Mukai K, et al. Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma. Histopathology 2008;52:409-11.
36. Lu HS, Gan MF, Zhou T, Wang SZ. Sarcomatoid thymic carcinoma arising in metaplastic thymoma: a case report. Int J Surg Pathol 2011;19:677-80.
37. Hasserjian RP, Klimstra DS, Rosai J. Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature. Am J Surg Pathol 1995;19:835-41.
38. Porubsky S, Rudolph B, Rückert JC, et al. International Thymic Malignancy Interest Group (ITMIG). EWSR1 translocation in primary hyalinising clear cell carcinoma of the thymus. Histopathology 2019;75:431-6.
39. Matsuno Y, Morozumi N, Hirohashi S, Shimosato Y, Rosai J. Papillary carcinoma of the thymus: report of four cases of a new microscopic type of thymic carcinoma. Am. J Surg Pathol 1998;22:873-80.
40. Oka S, Inoue M, Honda Y, et al. Thymic papillary adenocarcinoma coexisting with type A thymoma: a case report. Int J Surg Case Rep 2019;57:142-44.
41. Kalhor N, Moran CA. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Hum Pathol 2018;74:73-82.
42. Moser B, Schiefer AI, Janik S, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol 2015;39:541-8.
43. Kwon AY, Han J, Chu J, et al. Histologic characteristics of thymic adenocarcinomas: clinicopathologic study of a nine-case series and a review of the literature. Pathol Res Pract 2017;213:106-12.
44. Maeda D, Ota S, Ikeda S, et al. Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma. Lung Cancer 2009;64:22-7.
45. Sakanoue I, Hamakawa H, Fujimoto D, et al. KRAS mutation-positive mucinous adenocarcinoma originating in the thymus. J Thorac Dis 2017;9:E694-7.
46. Lee Y, Park S, Lee SH, Lee H. Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma. BMC Cancer 2017;17:330.
47. Maghbool M, Ramzi M, Nagel I, et al. Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature. BMC Clin Pathol 2013;13:17.
48. Takahashi K, Yoshida J, Nishimura M, Nagai K. Thymic carcinoma. Outcome of treatment including surgical resection. Jpn J Thorac Cardiovasc Surg 2000;48:494-8.
49. Chau NG, Ma C, Danga K, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr 2019;4:pkz094.
50. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009;33:984-91.
51. French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22:4135-9.
52. Gökmen-Polar Y, Cano OD, Kesler KA, Loehrer PJ, Badve S. NUT midline carcinomas in the thymic region. Mod Pathol 2014;27:1649-56.
53. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 2003;63:304-7.
54. French CA, Rahman S, Walsh EM, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov 2014;4:928-41.
55. Shiota H, Elya JE, Alekseyenko AA, et al. “Z4” complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism. Mol Cancer Res 2018;16:1826-33.
56. Banki F, Khalil K, Kott MM, Cota AL. Adenoid cystic carcinoma of the thymus gland: a rare tumor. Ann Thorac Surg 2010;90:e56-8.
57. Yang MQ, Bai LL, Wang Z, Huang WJ, Jiang GY, Xu HT. Primary thymic carcinoma with adenoid cystic carcinoma-like features: a case report and literature review. Medicine (Baltimore) 2020;99:e21531.
58. Kanzaki R, Ikeda N, Okura E, et al. Thymic carcinoma with adenoid cystic carcinomalike features with distant metastases. Ann Thorac Cardiovasc Surg 2012;18:544-7.
59. Toprani TH, Tamboli P, Amin MB, Ordoñez NG, Ayala AG, Ro JY. Thymic carcinoma with rhabdoid features. Ann Diagn Pathol 2003;7:106-11.
60. Maralakunte M, Singh L, Debi U, Karki T, Aggarwal D, Bal A. Malignant rhabdoid tumor of the mediastinum: a rare variant of thymic carcinoma presenting as superior vena caval syndrome. Arch Clin Med Case Rep 2020;4:717-23.
61. Franke A, Ströbel P, Fackeldey V, et al. Hepatoid thymic carcinoma: report of a case. Am J Surg Pathol 2004;28:250-6.
62. Jeong JS, Kang HJ, Jo U, Song MJ, Nam SY, Song JS. Hepatoid thymic carcinoma: a case report of a rare subtype of thymic carcinoma. J Pathol Transl Med 2021;55:230-4.
63. Nonaka D, Rodriguez J, Rollo JL, Rosai J. Undifferentiated large cell carcinoma of the thymus associated with Castleman disease-like reaction: a distinctive type of thymic neoplasm characterized by an indolent behavior. Am J Surg Pathol 2005;29:490-5.
64. Ströbel P, Hartmann M, Jakob A, et al. Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med 2004;350:2625-6.
65. National Comprehensive Cancer network. NCCN clinical practice guidelines in oncology (NCCN guidelines) Thymoma and Thymic carcinoma. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx [Last accessed on 24 Mar 2022].
